Charles Theuer | President & CEO |
Scott Brown | Director, Controller |
Maury Raycroft | Jefferies |
Jake Colby | BTIG |
Good day, ladies and gentlemen, and welcome to the TRACON Pharmaceuticals First Quarter 2019 Earnings Conference Call. At this time, all callers are in a listen-only mode. After the speaker's prepared remarks, we will conduct a question-and-answer session and instructions will be given at that time.
During today's call we'll be making certain forward-looking statements, including statements regarding expected timing of clinical trials and results, regulatory activities, future expenses and cash runway, and our development plans and strategy. These statements are subject to various risks that are described in our filings made with the Securities and Exchange Commission, including our Annual Report on Form 10-K for the year ended December 31, 2018 and subsequent quarterly reports on Form 10-Q.